Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

285.30
Delayed Data
As of Dec 07
 -5.86 / -2.01%
Today’s Change
223.02
Today|||52-Week Range
333.65
-6.87%
Year-to-Date
Can Biogen Beat the Broader Markets in 2017?
Dec 06 / MotleyFool.com - Paid Partner Content
3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline
Dec 01 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks
Dec 06 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Amgen
Nov 30 / MotleyFool.com - Paid Partner Content
4 Factors That Catapulted Ionis Pharmaceuticals Inc. 68% Higher in November
Dec 04 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for...
Nov 30 / Zacks.com - Paid Partner Content
Why Eli Lilly Shares Lost 8% in November
Dec 03 / MotleyFool.com - Paid Partner Content
Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?
Nov 25 / Zacks.com - Paid Partner Content
John Paulson's Largest 3rd Quarter Trades
Dec 01 / GuruFocus News - Paid Partner Content
Lilly's Alzheimer Drug Fails Phase III Study, Stock Down
Nov 24 / Zacks.com - Paid Partner Content
GW Pharmaceuticals (GWPH): What Awaits in Q4 Earnings?
Dec 01 / Zacks.com - Paid Partner Content